Related Experiment Video
Updated: Aug 6, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Racial and Ethnic Disparities in Research and Clinical Trials
Nicole C Syder1, Nada Elbuluk1
1Department of Dermatology, Keck School of Medicine, University of Southern California, 830 South Flower Street, Ste 100, Los Angeles, CA 90017, USA.
Abstract:
Clinical trials are an essential component of research for determining the safety and efficacy of treatments for medical diseases. In order for the results of clinical trials to be generalizable to diverse populations, they must include participants at ratios that are reflective of national and global populations. A significant number of dermatology studies not only lack racial/ethnic diversity but also fail to report data on minority recruitment and enrollment. Reasons for this are multifold and are discussed in this review. Although steps have been implemented to improve this issue, greater efforts are needed for sustained and meaningful change.
Insights
Clinical trials need diverse participants for generalizable results. Many dermatology studies lack racial/ethnic diversity and reporting, requiring improved recruitment efforts for equitable medical research.
Area of Science:
- Medical research
- Clinical trial methodology
- Dermatology
Background:
- Clinical trials are crucial for evaluating treatment safety and efficacy.
- Generalizability of trial results depends on participant diversity reflecting national/global populations.
- Dermatology studies often lack racial/ethnic diversity and fail to report minority enrollment data.
Purpose of the Study:
- To review the challenges and importance of diversity in clinical trials.
- To highlight the deficit in racial/ethnic diversity and data reporting in dermatology studies.
- To discuss reasons for underrepresentation and suggest improvements.
Main Methods:
- Literature review of dermatology clinical trials.
- Analysis of diversity metrics and reporting practices.
- Discussion of factors influencing minority participation.
Main Results:
- A significant number of dermatology studies exhibit insufficient racial/ethnic diversity.
- Data on minority recruitment and enrollment are frequently missing.
- Multiple factors contribute to these disparities in clinical trial participation.
Conclusions:
- Improving diversity in clinical trials is essential for equitable healthcare.
- Current efforts to enhance diversity in dermatology studies are insufficient.
- Sustained and meaningful changes in recruitment and reporting are necessary.
Related Concept Videos
Stereotypes, Prejudice, and Discrimination
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bias in Epidemiological Studies
Ethics in Research
Clinical Trials: Overview
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...

